Referenced Papers | Replenitol for fertility and PCOS

References

1 Carmina E, Lobo RA, Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2004 Sep;82(3):661- 5.

2 De Ugarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83:1454–60.

3 Dusková M et al. What may be the markers of the male equivalent of polycystic ovary syndrome? Physiol Res. 2004;53(3):287-94.

4 Sam S, Dunaif A et al, Metabolic phenotype in the brothers of women with PCOS. Diabetes Care. 2008 Jun;31(6):1237-41

5 Coviello AD, Sam S, Legro RS, Dunaif A, High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metab. 2009 Nov;94(11):4361-6

6 Kennington AS et al. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1990 Aug 9;323(6):373-8.

7 Ikezaki, Hiroaki et al. The utility of urinary myo-inositol as a marker of glucose intolerance. Diabetes Res Clin Pract. 2014 Jan;103(1):88-96.

8 Kennington AS et al. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1990 Aug 9;323(6):373-8.

9 Daughaday WH, Larner J, The renal excretion of inositol in normal and diabetic human beings. J Clin Invest. 1954 Mar;33(3):326-32.

10 Garg D, Tal R. Inositol Treatment and ART Outcomes in Women with PCOS. Int J Endocrinol. 2016 Epub http://dx.doi.org/10.1155/2016/1979654.

11 Chiu TT et al, Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002 Jun;17(6):1591-6.

12 Calogero AE et al, Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study. Andrology. 2015 May;3(3):491-5

13 Diamanti-Kandarakis E, Dunaif A, Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications. Endocrine Reviews 33: 981–1030, 2012

14 G. Carlomagno, V. Unfer, Inositol safety: clinical evidence. Eur Rev Med & Pharm Sci 2011: 15: 931-6

15 Zacchè et al, Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Gynecol Endocr Aug 2009; 25(8): 508-513

16 Minozzi M, Costantino D et al, The effect of a combination therapy with myo-inositol and a combined OCP versus a combined OCP alone on metabolic, endocrine, and clinical parameters in PCOS. Gynecol Endocrinol. 2011 Nov;27(11):920-4.

17 Capasso I, Esposito E et al, Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo controlled trial. Trials 2013, 14:273

18 Santamaria A et al, One year effects of myo-inositol in postmenopausal women with metabolic syndrome. Climacteric 2012; 15: 490-495

19 Kamenov Z et al, Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecol Endocrinol. 2015 Feb;31(2):131-5.

20 Brusco GF &, Mariani M, Inositol: effects on oocyte quality in patients undergoing ICSI. An open study. Eur Rev Med Pharmacol Sci. 2013 Nov;17(22):3095-102.

21 Artini P, Di Berardino O et al, Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome – A randomised study. Gynec Endoc, 2013; 29(4): 375- 379

22 Caprio F, D’Eufemia MD et al, Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. J Ovarian Res. 2015 Jun 12;8:37.

23 Lisi F, Carfagna P et al, Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol. 2012 Jul 23;10:52.

24 Palomba S et al, Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial. Fertil Steril. 2011 Nov;96(5):1128-33.

25 Rubino P, Palini S et al, Improving fertilization rate in ICSI cycles by adding myoinositol to the semen preparation procedures: a prospective, bicentric, randomized trial on sibling oocytes. J Assist Reprod Genet. 2015 Mar;32(3):387-94.

26 Palmieri M, Papale P et al, In Vitro Antioxidant Treatment of Semen Samples in Assisted Reproductive Technology: Effects of Myo-Inositol on Nemaspermic Parameters. Int J Endocrinol. 2016;2016:2839041

27 Gulino FA, Leonardi E et al, Effect of treatment with myo-inositol on semen parameters of patients undergoing an IVF cycle: in vivo study. Gynecol Endocrinol. 2016;32(1):65-8.

28 Calogero AE et al, Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study. Andrology. 2015 May;3(3):491-5.

29 O’Sullivan EP, G. Avalos G et al, Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria Diabetologia (2011) 54:1670–1675

30 http://www.nhs.uk/Conditions/Diabetes/Pages/Diabetes. aspx

31 D’Anna R et al, Myo-Inositol Supplementation and Onset of Gestational Diabetes Mellitus in Pregnant Women With a Family History of Type 2 Diabetes - a prospective, randomized, placebo-controlled study. Diabetes Care, Vol 36, April 2013: 854-857

32 Santamaria A, Di Benedetto A et al, Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med. 2016 Oct;29(19):3234-7.

33 D’Anna R, Di Benedetto A et al, Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial. Obstet Gynecol. 2015 Aug;126(2):310-5

34 Matarrelli B, Vitacolonna E et al. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013 Jul;26(10):967-72.

35 Holub BJ. Metabolism and function of myo-inositol and inositol phospholipids. Annu Rev Nutr. 1986;6:563-97. doi: 10.1146/annurev.nu.06.070186.003023. PMID: 2425833.

36 Clements RS Jr, Darnell B. Myo-inositol content of common foods: development of a high myo-inositol diet. Am J Clin Nutr. 1980 Sep;33(9):1954-67. doi: 10.1093/ajcn/33.9.1954. PMID: 7416064.

37 Emekçi Özay Ö, Özay AC, Çaglıyan E, Okyay RE, Gülekli B. Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial. Gynecol Endocrinol. 2017 Jul;33(7):524-528. doi: 10.1080/09513590.2017.1296127. Epub 2017 Mar 3. PMID: 28277112.

38 Amaefule CE, et al. Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo controlled, double-blind pilot trial with nested qualitative study BMJ Open 2022;12:e050110. doi:10.1136/ bmjopen-2021-050110.